Home › Funds › Clark Capital Management Group, Inc. › RPRX

Clark Capital Management Group, Inc. position in RPRX

ROYALTY PHARMA PLC · Health Care

Clark Capital Management Group, Inc. reported holding 1,663,003 shares of RPRX (ROYALTY PHARMA PLC) in its Q2 2026 13F filing — a position valued at US$93.2M, representing 0.51% of its reported portfolio and ranking #48 among its reported holdings. Clark Capital Management Group, Inc. has disclosed RPRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.66M sh
Reported value held$93.24M
Portfolio Weight0.51%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Clark Capital Management Group, Inc.'s RPRX position evolved

Clark Capital Management Group, Inc. first disclosed a stake in RPRX in Q3 2025 at 1,751,842 shares (US$61.8M). The position peaked in Q2 2026 at 1,663,003 shares, worth US$93.2M. Across 4 filings, Clark Capital Management Group, Inc. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,663,003 shares valued at US$93.2M — an increase of 23,035 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.75M $61.80M New
Q4 2025 1.75M $67.77M Hold
Q1 2026 1.64M $78.67M Reduce
Q2 2026 1.66M $93.24M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 49 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Clark Capital Management Group, Inc. held RPRX?

Clark Capital Management Group, Inc. has disclosed RPRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Clark Capital Management Group, Inc.'s current position in RPRX?

As of Q2 2026, Clark Capital Management Group, Inc. holds 1.66M shares of RPRX (ROYALTY PHARMA PLC), valued at $93.24M, representing 0.51% of its reported portfolio and ranking #48.

Has Clark Capital Management Group, Inc. been buying or selling RPRX?

In the latest 13F filing (Q2 2026), Clark Capital Management Group, Inc. increased its position in RPRX. The position peaked in Q2 2026 at 1.66M shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.